+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Not Verified

Australian Vision Research (AVR) Grants

Australian Vision Research

Australian Vision Research (AVR) provides seed grants to support innovative and clinically relevant research that advances eye health and vision science.

Grants are open to Ophthalmologists and trainee Ophthalmologists for research conducted in ophthalmic research institutes or equivalent ophthalmic led university departments focused on vision research.

Applications that have already secured funding elsewhere are not eligible. AVR reserves the right to request copies of previous grant applications submitted to other bodies to determine funding eligibility.

At least one investigator in the team must be:

A Fellow of the Royal Australian and New Zealand College of Ophthalmologists (RANZCO); AND
A current AVR member (i.e., a RANZCO Fellow who has registered as an AVR member and holds current membership), and
All RANZCO Fellows listed on the application as investigators must also be current AVR members

For overseas co-investigators:

The majority of the project work must be conducted in Australia, and the project must be administered through an Australian institution.
The lead CI can not be an overseas investigator.

Grant size:

AVR will consider funding individual grants of up to $70,000 for one year.

AI Based Application Success Predictor

Although AVR does not publish formal predictors, its criteria and priorities clearly indicate what leads to success:

✔ 1. Clinical Relevance to Vision Loss (MOST IMPORTANT)

Projects must address:

eye disease

prevention of blindness

improvement in patient outcomes

👉 Strongest predictor:
Clear impact on vision health or clinical practice

✔ 2. Translational Impact

Preference for research that:

moves from lab → clinic

improves diagnosis or treatment

👉 AVR prioritizes real-world application

✔ 3. Scientific Merit & Quality

Strong:

study design

hypothesis

methodology

👉 Peer review ensures high scientific standards

✔ 4. Feasibility Within Moderate Funding

Projects must be:

achievable within $65K budget

realistic within timeframe

👉 Overly complex proposals are less competitive

✔ 5. Investigator Expertise

Applicants are typically:

ophthalmologists

vision scientists

clinical researchers

👉 Track record and institutional support matter

✔ 6. Alignment with Major Eye Diseases

Higher success for work targeting:

macular degeneration

glaucoma

retinal disease

surgical innovation

✔ 7. Potential for Patient Impact

Projects that:

improve treatment

enhance early detection

reduce blindness risk

👉 Strong predictor: clear benefit to patients

✔ 8. Collaboration & Institutional Strength

Projects linked to:

hospitals

universities

clinical networks

are more competitive

✔ 9. Innovation in Ophthalmology

Novel:

diagnostic tools

therapies

surgical techniques

increase competitiveness

✔ 10. Future Funding Potential

Like many foundations, AVR favors projects that can:

lead to larger grants (e.g., NHMRC)

scale into major clinical trials

📌 What Is NOT Publicly Available

AVR does not publish:

numerical scoring systems

funding probability models

cut-off thresholds

🧾 Key Insight

👉 AVR is a mid-scale, clinically focused funder (between small foundations and national agencies).

Practical “Success Formula”

Strong AVR grant =

Clinical relevance + translational impact + scientific rigor + feasibility + patient benefit

📌 Summary

Australian Vision Research (AVR) is a nonprofit funder of ophthalmic research aimed at preventing blindness and improving eye health.

It provides competitive grants (~$65K) across all major eye diseases.

While it does not publish formal success predictors, funding success is strongly driven by:

clinical and translational impact

scientific quality

feasibility within budget

alignment with major eye health challenges

potential to improve patient outcomes

Specialties

Ophthalmology

Eligibility Requirements

General Grant Eligibility

Investigators who were successful in the previous year are not eligible to apply, unless they acted as a supervisor on a Priming Grant.
An investigator may be included on only one AVR submission per year.
At least one investigator in the team must be a current RANZCO Fellow and AVR member.
All RANZCO fellows who are investigators must also be AVR members
Funding will not be available for travel to conferences.
Applications not meeting formatting requirements will be deemed ineligible.
The administering institution must be an ophthalmic research institutes or equivalent ophthalmic led university department focused on vision research.
Other Sources of Funding: Applicants must disclose all current or planned applications to other funding bodies for the same or a related project. The Research Advisory Committee may verify the details of any additional or concurrent funding.
The investigator CVs must include the names of all CIs, grant title, granting body, duration of the grant and funding amount to be eligible.

If a project funded by AVR subsequently receives funding from another source for the same or a substantially similar project, AVR may request a copy of the other successful application to assess potential overlap. Based on this assessment, the Committee may reduce or withdraw AVR funding to avoid duplication of support.

Successful applicants must promptly notify AVR of any additional funding obtained or expected for the same or a related project. Decisions of the Research Advisory Committee in these matters are final.

Priming Grant Eligibility

The AVR Priming Grant supports early-stage clinician-researchers.

Eligibility Requirements:

Applicants must be both a RANZCO Fellow and a current AVR member.
Applicants should have a limited track record of research, for example:
– Within 5 years of completing their highest research qualification (PhD, MD, or equivalent), OR
– Within 5 years of commencing a research career (including career changes or return from a career break).
Applicants must not have received prior AVR funding.
All investigators on the application must provide a CV.
The Chief Investigator must meet Priming Grant criteria; other team members may be included but do not need to meet these criteria.
AVR aims to fund at least one Priming Grant each year (more may be awarded depending on applications).
Extensions to the 5-year rule will be considered for career interruptions (e.g. parental leave, illness). This is at the discretion of the AVR Research Advisory Committee.

Pre-submission discussions with the AVR Research Advisory Committee are encouraged (non-binding). Contact grants@australianvisionresearch.org at least 21 days prior to submission.

Sponsored Grant Eligibility

ANZSRS Sponsored Grant

The Australian and New Zealand Society of Retinal Specialists (ANZSRS) has commitment to provide $60,000 to support research, with a preference for awarding the grant to projects where a full ANZSRS member is listed as part of the investigative team. This prioritisation reflects ANZSRS’s dedication to supporting the professional development and research impact of its members.

Sponsor Details

Sponsor Institute/Organizations: Australian Vision Research

Sponsor Type: Corporate/Non-Profit

Address: PO Box 3109, Erina, NSW 2250

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity